icone plus
Contact
Abonnez-vous aux actualités
Reason for request
Inclusion
Clinical Benefit
Substantial
Substantial actual benefit
Clinical Added Value
no clinical added value
EYLEA 40 mg/ml, solution for injection in a prefilled syringe and solution for injection in a vial, does not provide an improvement in actual benefit (IAB V) compared with LUCENTIS 10 mg/ml, solution for injection.
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
cLnw6JvqsG3nasaH